1.5 minute read
Recently, an independent panel of vaccine experts recommended the Moderna booster shots to those who are at high risk of contracting COVID-19. This includes people over the age of 65, younger adults with health issues, and those with occupational exposure to COVID-19.
This nonbinding panel advises the Food and Drug Administration (FDA) and encouraged half-dose Moderna vaccine shots for those who previously received that vaccine. The FDA usually follows the panel’s endorsement guidance, recently making the same recommendation regarding the Pfizer-BioNTech vaccine.
The latest recommendation is for the vulnerable populations only. There is no current evidence to suggest that most Americans need a booster shot at this time. The FDA has only reviewed Pfizer and Moderna booster shots. The panel is expected to review Johnson & Johnson soon.
Individuals should continue to monitor the FDA for updates. Download the bulletin for more details.
This blog is intended to be a compilation of information and resources pulled from federal, state, and local agencies. This is not intended to be legal advice. For up to the minute information and guidance on COVID-19, please follow the guidelines of the Centers for Disease Control and Prevention (CDC) and your local health organizations.
National Insurance Services is not a law firm and no opinion, suggestion, or recommendation of the firm or its employees shall constitute legal advice. Readers are advised to consult with their own attorney for a determination of their legal rights, responsibilities and liabilities, including the interpretation of any statute or regulation, or its application to the readers’ business activities.
